BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15176999)

  • 1. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
    Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
    J Bone Miner Res; 2006 Mar; 21(3):446-55. PubMed ID: 16491293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paget's disease-a VDR coactivator disease?
    Kurihara N; Ishizuka S; Demulder A; Menaa C; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):321-5. PubMed ID: 15225793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
    Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
    J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
    Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
    Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.
    Kurihara N; Reddy SV; Menaa C; Anderson D; Roodman GD
    J Clin Invest; 2000 Mar; 105(5):607-14. PubMed ID: 10712432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
    Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental models of Paget's disease.
    Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P55-7. PubMed ID: 17229020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
    Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
    J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
    Oba Y; Chung HY; Choi SJ; Roodman GD
    J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
    Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
    Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
    Shanmugarajan S; Youssef RF; Pati P; Ries WL; Rao DS; Reddy SV
    J Cell Biochem; 2008 Jul; 104(4):1500-8. PubMed ID: 18348201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.
    Nagata Y; Miyagawa K; Ohata Y; Petrusca DN; Pagnotti GM; Mohammad KS; Guise TA; Windle JJ; David Roodman G; Kurihara N
    J Cell Biochem; 2021 Apr; 122(3-4):335-348. PubMed ID: 33107091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.
    Miyagawa K; Ohata Y; Delgado-Calle J; Teramachi J; Zhou H; Dempster DD; Subler MA; Windle JJ; Chirgwin JM; Roodman GD; Kurihara N
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32078587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
    Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
    Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation.
    Sun Q; Sammut B; Wang FM; Kurihara N; Windle JJ; Roodman GD; Galson DL
    J Bone Miner Res; 2014 Jan; 29(1):90-102. PubMed ID: 23794264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell biology of Paget's disease.
    Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.